arrow
S

Susan L. Slager

mayo clinic
H指数:79
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Perinatal and Early-Life Exposures and Risk of Non-Hodgkin Lymphoma

围产期和早期生命暴露与非霍奇金淋巴瘤风险

Cancers
IF4.4
2026-08-280
OA
MRI Deep Learning for Differentiating Glioblastoma, IDH Wild-type from Central Nervous System Diffuse Large B-cell Lymphoma

MRI深度学习用于区分胶质母细胞瘤(IDH野生型)与中枢神经系统弥漫性大B细胞淋巴瘤

2026-05-010
PRE
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes

血清中高水平的可溶性肿瘤坏死因子受体2与主要淋巴瘤亚型的不良总生存期相关

2026-03-270
PRE
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

ULK4和CDKN2A基因多态性影响不明原因单克隆丙种球蛋白病的发病风险

2026-03-110
OAAI
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study

胰岛素样生长因子I(IGF-I)循环水平与多发性骨髓瘤风险:一项观察性和孟德尔随机化研究

2026-03-010
OAAI
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy

滤泡性淋巴瘤患者一线免疫化疗后的无事件生存期全基因组关联研究

2026-01-090
OAAI
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)

CHIP在单克隆B细胞淋巴增生病(MBL)患者中增加了患淋巴系统恶性肿瘤的风险。

2025-11-060
OAAI
Differentiation of IDH-Wildtype Glioblastoma and Primary Central Nervous System Lymphoma Using 3D Deep Learning on MRI

利用3D深度学习在MRI上区分IDH-Wildtype胶质母细胞瘤和原发性中枢神经系统淋巴瘤

2025-11-010
OAAI
Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses

遗传决定的体质指数与多基因和孟德尔随机化分析中的弥漫性大B细胞淋巴瘤相关。

2025-09-050
OAAI
Identification of four autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

鉴定四种自噬相关遗传变异为慢性淋巴细胞白血病的风险因素

2025-09-050
OAAI
European-based polygenic risk score and genome-wide association study of B-cell non-Hodgkin lymphoma subtypes in Israeli Jews and Palestinian Arabs

基于欧洲的B细胞非霍奇金淋巴瘤亚型的多基因风险评分和全基因组关联研究,在以色列犹太人和巴勒斯坦阿拉伯人中进行

2025-08-310
OAAI
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee

单克隆B细胞淋巴增多症(MBL)的最新生物学、进展和临床管理:Intercepting Blood Cancers Workshop Committee的共识报告

2025-08-290
OAAI
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis

高计数单克隆B细胞淋巴细胞增多症中影像学研究在预测首次治疗时间及总生存期方面的作用

2025-07-150
PRE
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry

非洲血统患者慢性淋巴细胞白血病的基因组特征

2025-02-061
OA
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism
2025-01-010
PRE
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era
LEUKEMIA
IF13.4
2024-12-100
PRE
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome
2024-11-110
OAAI
Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)

单克隆b细胞淋巴细胞增多症 (MBL) 患者的镶嵌染色体改变 (mCAs)

2024-11-060
OAAI
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
2024-08-080
OAAI